society cannabis 
Hospital Pharmacy Europe
JUNE 14, 2023
With increasing evidence that cannabis use is associated with adverse cardiovascular effects, questions are undoubtedly being asked about the safety of the drug for medical uses. Since the publication of the AHA statement, more evidence has come to light, which suggests that the use of cannabis has several adverse effect on the CV system.
European Pharmaceutical Review
APRIL 13, 2023
As psychedelics diffused into wider society and recreational use increased, some individuals reported…ongoing symptoms after the drugs had left the body” At a time when psychiatry lacked effective medical therapies, the discovery of LSD was of interest. World Health Organization. World Health Organization; 2022 [cited 2023Mar].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
SEPTEMBER 18, 2023
Cyclobenzaprine and cannabis While taking cyclobenzaprine, avoid cannabis or CBD. Cyclobenzaprine and older adults The American Geriatrics Society’s Criteria for potentially inappropriate medication use in older adults outlines medications that may not be safe for older adults (generally 65 years or older).
Hospital Pharmacy Europe
SEPTEMBER 7, 2022
The risk of developing a new-onset arrhythmia is higher in patients prescribed cannabis for chronic pain compared to those not using the drug. Cannabis represents a generic term used to denote the several psychoactive preparations of the plant Cannabis sativa and according to the World Health Organisation, around 147 million people, 2.5%
The Guardian - Pharmaceutical Industry
FEBRUARY 17, 2024
Last month he delivered his first consignment of high-strength cannabis. Dehon’s dope is legal and above board, produced to supply the UK’s burgeoning market for medical cannabis on prescription. What’s more, Dehon and his colleagues believe it is the first carbon-neutral indoor weed grown anywhere in the world.
The Checkup by Singlecare
JULY 17, 2023
According to the recently updated guidelines American Geriatrics Society (AGS) Beers Criteria ® (AGS Beers Criteria ® ) for Potentially Inappropriate Medication (PIM) Use in Older Adults, benzodiazepines are not recommended for use in adults ages 65 years and older.
The Guardian - Pharmaceutical Industry
MAY 15, 2023
British crown dependency hopes to license as many as 10 medicinal cannabis firms by end of 2025 The Isle of Man has for decades been dominated by offshore financial services , but now its government is planning a push for a new kind of economic growth: medicinal cannabis.
Expert insights. Personalized for you.
98 
Let's personalize your content